Cover Image
市場調查報告書

全球抗壞血酸市場:成長,趨勢及預測(2017年∼2022年)

Global Ascorbic Acid Market - Segmented by Type, Source, Application and Geography (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 572856
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球抗壞血酸市場:成長,趨勢及預測(2017年∼2022年) Global Ascorbic Acid Market - Segmented by Type, Source, Application and Geography (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 110 Pages
簡介

全球抗壞血酸市場,2016年記錄8億6080萬美元,從預測期間的2017年到2022年以4.9%的CAGR(年複合成長率)發展,到2022年規模將會擴大到10億9310萬美元。以飲食習慣和生活習慣的變化作為背景對積極攝取維他命的興趣高漲成為這個市場的成長要素。

本報告提供抗壞血酸的全球市場調查,市場概要,各終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面的資訊。

目錄

第1章 簡介

  • 主要調查結果
  • 調查的前提條件
  • 市場定義

第2章 調查手法

  • 簡介
  • 調查的時間軸
  • 調查的階段
    • 2次調查
    • 統計分析

第3章 主要觀察

第4章 市場動態

  • 成長要素
    • 食品及健康輔助食品的需求的增加
    • 多樣的終端用戶產業的技術進步
  • 阻礙因素
    • 原料價格的變動
    • 替代品的取得的好處
  • 市場機會
    • 亞太地區市場上潛在的需求
    • 主要企業的研究開發投資的擴大
  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代產品的威脅。服務
    • 競爭度

第5章 市場區隔

  • 各終端用戶
    • 醫藥品
    • 食品、飲料
    • 個人保養品
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 非洲

第6章 競爭情形

  • 主要企業的策略
  • 過去5年最積極的企業
  • 市場佔有率分析

第7章 企業簡介

  • DSM
  • Northeast Pharmaceutical Group
  • Shandong Luwei Pharmaceutical
  • Bactolac Pharmaceutical Inc
  • Aland Nutraceuticals Group
  • DuPont
  • FreShine
  • Luckerkong Biotech
  • King-pharm
  • Top science
  • BASF
  • Dishman Group
  • GlaxoSmithKline Plc
  • CSPC Pharmaceutical Group

第8章 附錄

  • 免責聲明
  • 參考資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 34884

The market accounted for USD 860.8 million in 2016 and is expected to reach USD 1103.15 million by 2023, registering a CAGR of 5.1% during the forecast period of 2018-2023.

Ascorbic acid, with its salt derivatives, and ascorbyl palmitate is classified as food additives by the European Community and registered as 'Generally Recognized as Safe' (GRAS) substance by the US Food & Drug Administration (FDA), which has accelerated the demand for ascorbic acid from food & beverages industry in the European region.

Increasing vitamin deficiencies

The global ascorbic acid market is expected to witness a high growth rate in the coming decade, owing to vitamin deficiency concerns caused due to changing lifestyles and dietary habits, around the world. Asia-Pacific is expected to be the fastest growing market for ascorbic acid, during the forecast period, due to the growing demand and the availability of low-cost manufacturing facilities in China. The North American and European markets are set to grow due to the rising health issues like diabetes which in turn is fueling the demand for ascorbic acid as a substitute for low-calorie sweetener.

Asia-Pacific holds the largest market share

Ascorbic acid, a common source of vitamin C, is used in various important end-use industries. The market is segmented based on end-user, into pharmaceuticals, food & beverages, personal care and others. Ascorbic acid finds a major application in the pharmaceutical industry with the manufacture of antioxidants. The food & beverage industry holds a major share and is growing at a high rate, owing to the rising health issues, thus, acting as a substitute for sweeteners. Asia-Pacific holds the largest market share.

Major Players: DSM, NORTHEAST PHARMACEUTICAL GROUP, SPEC-CHEM, SHANDONG LUWEI PHARMACEUTICA, TOPSCIENCE, BACTOLAC PHARMACEUTICAL Inc., LUCKERKONG BIOTECH, ALAND NUTRACEUTICALS GROUP, KING-PHARM, CHENGXIN PHARMA, FRESHINE

Reasons to Purchase this Report

Analyzing outlook of the market with the recent trends and Porter's five forces analysis

Market dynamics which essentially consider the factors which are impelling the present market scenario along with growth opportunities of the market in the years to come

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects

Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market

Competitive landscape involving the market share of major players along with the key strategies adopted for development in the past five years

Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis and strategies employed by the major market players

3 months analyst support along with the Market Estimate sheet in excel.

Customization of the Report

Value chain analysis

Consumer behavior analysis in country level

Table of Contents

1. INTRODUCTION

  • 1.1 Key Deliverables of the Study
  • 1.2 Study Assumptions
  • 1.3 Market Definition

2. RESEARCH APPROACH & METHODOLOGY

  • 2.1 Introduction
  • 2.2 Study Timeline
  • 2.3 Study Phases
    • 2.3.1 Secondary Research
    • 2.3.2 Statistical Analysis
    • 2.3.3 Expert Validation

3. KEY FINDINGS

4. MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Demand for Food and Health Supplements
    • 4.1.2 Technological Advancements in Various Application Industries
  • 4.2 Restraints
    • 4.2.1 Fluctuation in raw material prices
    • 4.2.2 Wide availability of immediate substitute
  • 4.3 Opportunities
    • 4.3.1 Potential demand in the Asia-Pacific market
    • 4.3.2 Growing investment in R&D by major companies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products & Services
    • 4.4.5 Degree of Competition

5. MARKET SEGMENTATION

  • 5.1 By End-User
    • 5.1.1 Pharmaceutical
    • 5.1.2 Food & Beverages
    • 5.1.3 Personal care
    • 5.1.4 Others
  • 5.2 By Geography
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia-Pacific
    • 5.2.4 South America
    • 5.2.5 Africa

6. COMPETITIVE LANDSCAPE

  • 6.1 Strategy adopted by Key players
  • 6.2 Most active companies in the past five years
  • 6.3 Market Share Analysis

7. COMPANY PROFILES

  • 7.1 DSM
    • 7.1.1 Overview
    • 7.1.2 Financials
    • 7.1.3 Product types
    • 7.1.4 Strategies
  • 7.2 Northeast Pharmaceutical Group
    • 7.2.1 Overview
    • 7.2.2 Financials
    • 7.2.3 Product types
    • 7.2.4 Strategies
  • 7.3 Shandong Luwei Pharmaceutical
    • 7.3.1 Overview
    • 7.3.2 Financials
    • 7.3.3 Product types
    • 7.3.4 Strategies
  • 7.4 Bactolac Pharmaceutical Inc
    • 7.4.1 Overview
    • 7.4.2 Financials
    • 7.4.3 Product types
    • 7.4.4 Strategies
  • 7.5 Aland Nutraceuticals Group
    • 7.5.1 Overview
    • 7.5.2 Financials
    • 7.5.3 Product types
    • 7.5.4 Strategies
  • 7.6 DuPont
    • 7.6.1 Overview
    • 7.6.2 Financials
    • 7.6.3 Product types
    • 7.6.4 Strategies
  • 7.7 FreShine
    • 7.7.1 Overview
    • 7.7.2 Financials
    • 7.7.3 Product types
    • 7.7.4 Strategies
  • 7.8 Luckerkong Biotech
    • 7.8.1 Overview
    • 7.8.2 Financials
    • 7.8.3 Product types
    • 7.8.4 Strategies
  • 7.9 King-pharm
    • 7.9.1 Overview
    • 7.9.2 Financials
    • 7.9.3 Product types
    • 7.9.4 Strategies
  • 7.10 Top science
    • 7.10.1 Overview
    • 7.10.2 Financials
    • 7.10.3 Product types
    • 7.10.4 Strategies
  • 7.11 BASF
    • 7.11.1 Overview
    • 7.11.2 Financials
    • 7.11.3 Product types
    • 7.11.4 Strategies
  • 7.12 Dishman Group
    • 7.12.1 Overview
    • 7.12.2 Financials
    • 7.12.3 Product types
    • 7.12.4 Strategies
  • 7.13 GlaxoSmithKline Plc
    • 7.13.1 Overview
    • 7.13.2 Financials
    • 7.13.3 Product types
    • 7.13.4 Strategies
  • 7.14 CSPC Pharmaceutical Group
    • 7.14.1 Overview
    • 7.14.2 Financials
    • 7.14.3 Product types
    • 7.14.4 Strategies

8. APPENDIX

  • 8.1 Disclaimer
  • 8.2 Sources
  • 8.3 Sources
Back to Top